Stoxx Europe 50
4.915,52
PKT
+73,51
PKT
+1,52
%
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.04.22 | Deutsche Telekom Overweight | Barclays Capital | |
| 01.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.04.22 | BNP Paribas Neutral | JP Morgan Chase & Co. | |
| 01.04.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 01.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 01.04.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 01.04.22 | Novo Nordisk Neutral | Credit Suisse Group | |
| 01.04.22 | Intesa Sanpaolo Neutral | Credit Suisse Group | |
| 01.04.22 | Santander Outperform | Credit Suisse Group | |
| 01.04.22 | UBS Outperform | Credit Suisse Group | |
| 01.04.22 | BBVA Neutral | Credit Suisse Group | |
| 01.04.22 | BNP Paribas Outperform | Credit Suisse Group | |
| 31.03.22 | Schneider Electric Overweight | JP Morgan Chase & Co. | |
| 31.03.22 | Rheinmetall Buy | Deutsche Bank AG | |
| 31.03.22 | Roche Buy | Deutsche Bank AG | |
| 31.03.22 | BBVA Hold | Deutsche Bank AG | |
| 31.03.22 | LOréal Overweight | JP Morgan Chase & Co. | |
| 31.03.22 | SAP Outperform | Credit Suisse Group | |
| 31.03.22 | Siemens Buy | Jefferies & Company Inc. | |
| 31.03.22 | HSBC Buy | Goldman Sachs Group Inc. | |
| 31.03.22 | BBVA Neutral | Goldman Sachs Group Inc. | |
| 31.03.22 | Santander Buy | Goldman Sachs Group Inc. | |
| 31.03.22 | UBS Neutral | Goldman Sachs Group Inc. | |
| 31.03.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 31.03.22 | Siemens Overweight | JP Morgan Chase & Co. | |
| 30.03.22 | Unilever Outperform | Credit Suisse Group | |
| 30.03.22 | Sanofi Outperform | Credit Suisse Group | |
| 30.03.22 | Nestlé Neutral | Credit Suisse Group | |
| 30.03.22 | Roche Overweight | Barclays Capital | |
| 30.03.22 | Roche Buy | Merrill Lynch & Co., Inc. | |
| 30.03.22 | Sanofi Buy | UBS AG | |
| 30.03.22 | Iberdrola SA Buy | Goldman Sachs Group Inc. | |
| 30.03.22 | Enel Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 30.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 30.03.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.03.22 | Roche Outperform | Bernstein Research | |
| 30.03.22 | UBS Sector Perform | RBC Capital Markets | |
| 30.03.22 | UBS Outperform | RBC Capital Markets |